Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
16 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BOSTON SCIENTIFIC BENELUX from Machelen (Brab.), company number BE0450258756, closed financial year 2025 with a result of € 2.1 million after tax. For that financial year BOSTON SCIENTIFIC BENELUX recorded revenue of € 76.6 million and equity of € 13 million. Compared with financial year 2024, the result moved from € 2.5 million to € 2.1 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 13 million
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2.1 million
▼ 13% vs 2024
Profit after tax over the fiscal year.
€ 1
▼ € 207 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 7.9 million.
People and assets in 2025
86.6
▲ 5.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 15.6 million
▲ 14% vs 2024
€ 179,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 10,367
▼ 34% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 12.2 million
▼ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 78 days on average.
€ 5 million
▲ 20% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 57,573,694 | € 65,938,170 | € 73,125,608 | € 76,625,246 | ▲ 5% |
| Profit after taxes | € 1,275,743 | € 1,355,816 | € 2,461,488 | € 2,145,710 | ▼ 13% |
| Equity | € 7,017,631 | € 8,373,447 | € 10,834,935 | € 12,980,645 | ▲ 20% |
| Total debts | € 16,828,530 | € 17,709,665 | € 21,895,568 | € 20,200,706 | ▼ 8% |
| Cash | - | - | € 208 | € 1 | ▼ € 207 |
| Retained profit | € 1,901,231 | € 3,257,047 | € 5,718,535 | € 7,864,245 | ▲ 38% |
| Balance sheet total | € 25,594,028 | € 28,017,397 | € 33,697,373 | € 33,960,881 | ▲ 1% |
| Employees (FTE) | 65.9 | 72.6 | 81.1 | 86.6 | ▲ 5.5 |
Key figures of BOSTON SCIENTIFIC BENELUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BOSTON SCIENTIFIC BENELUX?
What happened at BOSTON SCIENTIFIC BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Woodworth Emily stepped down as director. NBB
- J. Cronin Douglas stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.1 million (▼ 13% vs 2024). Source: NBB ↗
- Woodworth Emily became a director. NBB
- J. Cronin Douglas became a director. NBB
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 1.3 million profit in 2022 to € 2.1 million profit in 2025.
Paid € 3.3 million in corporate taxes since 2022.
Best year ever: 2024, with € 2.5 million profit.
Pays suppliers within 78 days on average.
A new publication or filing at BOSTON SCIENTIFIC BENELUX? We notify you, reason included.
Follow BOSTON SCIENTIFIC BENELUXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Boston Scientific International B.V. (100%) and Target Therapeutics, Inc. (0%).
Directors
According to the 2025 annual accounts
since 2024 · until 2030
J. Cronin Douglas
Director
since 2024 · until 2030
Shareholders
Boston Scientific International B.V.
100%
Target Therapeutics, Inc.
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lambroekstraat 5D
1831 Machelen (Brab.)
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
All companies at this address →Guidant Europe same network
€ 22.5 million revenue · 2025
SOFINDEV V
€ -2.1 million gross margin · 2025
SMGX
FPI Partners
Sofindev VI Investments (Privak)
+11 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
AMAZON-02 - Amazon.com, Inc., US
Domain
Domain
bostonscientific.com
Registered
1996-05-03
Registrar
CSC Corporate Domains, Inc.
Expires
2026-05-04
Website info
Features
Security
Network
Details
- Company number
- 0450.258.756
- VAT number
- BE 0450.258.756
- Registered office
- Lambroekstraat 5D, 1831 Machelen (Brab.)
- Names & denominations
- BOSTON SCIENTIFIC BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 2 June 1993
- Peppol
- Active · Active since 8 Sept 2022
- Contact
- bostonscientific.com
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Handelsbemiddeling gespecialiseerd in overige goederen, n.e.g.
Handelsbemiddeling in de groothandel in andere specifieke goederen
Vervaardiging van niet-elektrische apparaten en instrumenten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden